Cervarix offers HPV protection past 6 years, study shows

12/3/2009 | Yahoo!

A study that included almost 800 young women ages 15 to 25 found the new vaccine Cervarix offered protection against the human papillomavirus virus for longer than six years. Vaccine efficacy remained at 100% against 12-month persistent infection with HPV-16/18, the data showed.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Finance Manager - ENT
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA